本文轉載自原廠電子報: Biomedica | www.bmgrp.com | 電子報原文
|
|
|
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Smadja DM et al., Angiogenesis, 2020;1-10. Full text.
Elevated Angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients. Hultstrom M et al., MedRxiv preprint server, 2021. Full text
|
|
|
|
|
|
|
|
Angiopoietin-2 can easily be measured in human serum, plasma and urine samples
√ Low sample volume – only 10µl needed
√ Assay range optimized for clinical samples
√ Ready to use standards and 2 controls included
√ Rigorously validated according to international guidelines
√ Highly specific using epitope mapped antibodies
√ Kit developed and manufactured by Biomedica
|
|
|
|
|
|
Contact us at Biomedica – Angiopoietin-2, VEGF, Neuropilin-1 ELISA kits – Promotion 30% off (valid until June 30, 2021)
|
|
|
|
Your Biomedica Immunoassays Team
|
|
|
|
|
